Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

151.93 +4.93 (+3.35%)
Official Closing Price Updated: 4:53 PM EST, Jan 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Moderna Inc

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Moderna to Present at BMO 2020 Prescriptions for Success Healthcare Conference
Moderna to present at BMO 2020 Prescriptions for Success Healthcare Conference. 
From Business Wire News Releases
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Moderna, Inc. (MRNA) Investors of Ongoing Investigation into Possible Securities Fraud and Insider Trading, Encourages Investors with Significant Losse
From GlobeNewswire News Releases
Thinking about trading options or stock in iRobot, Moderna, Advanced Micro Devices, Wells Fargo, or Apple?
InvestorsObserver issues critical PriceWatch Alerts for IRBT, MRNA, AMD, WFC, and AAPL. 
From PR Newswire
Advanced Devices Give Patients More Flexibility for Managing Their Conditions
FinancialBuzz.com News Commentary 
From PR Newswire
Ray Jordan Joins Moderna as Chief Corporate Affairs Officer
Ray Jordan joins Moderna as Chief Corporate Affairs Officer. 
From Business Wire News Releases
MODERNA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
From GlobeNewswire News Releases
Thinking about buying stock in Tesla, Oasis Petroleum, Moderna, Callon Petroleum, or Nio Inc?
InvestorsObserver issues critical PriceWatch Alerts for TSLA, OAS, MRNA, CPE, and NIO. 
From PR Newswire
Moderna Advances Late-Stage Development of its Vaccine (mRNA-1273) Against COVID-19
Moderna advances late-stage development of its vaccine (mRNA-1273) against COVID-19 
From Business Wire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
From GlobeNewswire News Releases
Groundbreaking Designs Expand Remote Patient Monitoring Capabilities
FinancialBuzz.com News Commentary 
From PR Newswire
MODERNA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
From GlobeNewswire News Releases
U.S. Support For Drugmakers Fuels Effort To Secure Shortest Timeline For COVID-19 Vaccine
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
U.S. Support for Drugmakers Fuels Effort to Secure Shortest Timeline for COVID-19 Vaccine
Financialnewsmedia.com News Commentary 
From PR Newswire
Thinking about trading options or stock in Air Transport Services, AAR Corp, United Airlines, Eldorado Resorts, or Moderna?
InvestorsObserver issues critical PriceWatch Alerts for ATSG, AIR, UAL, ERI, and MRNA. 
From PR Newswire
David Meline Joins Moderna as Chief Financial Officer
David Meline joins Moderna as Chief Financial Officer. 
From Business Wire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
From GlobeNewswire News Releases
Doctors on the Front Lines Are Testing New Therapies to Treat COVID-19
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Doctors on the Front Lines Are Testing New Therapies to Treat COVID-19
Financialnewsmedia.com News Commentary 
From PR Newswire
Biotech Stocks Snapshot - Race for Testing and Vaccines for COVID-19 Sees Spike in Biotechnology Innovation
From Newsfile Corp News Releases
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Announces Investigation into Moderna, Inc. (MRNA) for Possible Securities Fraud and Insider Trading, Encourages Investors with Significant Losses to Contact Fi
From GlobeNewswire News Releases
MRNA Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Moderna, Inc. Investigation and Encourages Investors to Contact the Firm
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Moderna, Inc. ("Moderna" or "the Company") (NASDAQ: MRNA). Investors who purchased... 
From PR Newswire
NASDAQ: MRNA Shareholder Notice: Investigation over Possible Securities Laws Violations by Moderna, Inc.
San Diego, CA -- (SBWIRE) -- 06/02/2020 -- An investigation for investors in Moderna, Inc. (NASDAQ: MRNA) shares over potential securities laws violations by Moderna, Inc. was announced. 
From SBWire - Latest Press Releases
Moderna Highlights Advances in Platform Science and Innovative Vaccine Research at Third Annual Science Day
Moderna highlights advances in platform science and innovative vaccine research at third annual Science Day. 
From Business Wire News Releases
MODERNA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
From GlobeNewswire News Releases
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Possible Securities Fraud and Insider Trading, Encourages Moderna, Inc. (MRNA) Investors with Significant Losses to Contact Firm
Hagens Berman urges investors in Moderna, Inc. (NASDAQ: MRNA) to submit their losses now to learn if they qualify to recover their investment losses. 
From PR Newswire
Moderna Announces First Participants in Each Age Cohort Dosed in Phase 2 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
Moderna announces first participants in each age cohort dosed in Phase 2 Study of mRNA vaccine (mRNA-1273) against novel coronavirus. 
From Business Wire News Releases
Second Wave Concerns Create Urgent Need For Fast, Accurate Tests and Plausible Vaccines
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Second Wave Concerns Create Urgent Need For Fast, Accurate Tests and Plausible Vaccines
FN Media Group Presents Microsmallcap.com Market Commentary 
From PR Newswire
Flagship Pioneering Bolsters Executive Team with Appointment of Fabrice Chouraqui in Newly Created Dual Role of Flagship CEO-Partner and CEO of Cellarity
Flagship Pioneering, a unique life sciences innovation enterprise, today announced that it has further strengthened its executive leadership team with the appointment of Fabrice Chouraqui to the newly... 
From PR Newswire
CordenPharma & Moderna Extend Strategic Manufacturing Services Agreement for the Supply of Lipid Excipients to be used in Moderna's Vaccine (mRNA-1273) Against the Novel Coronavirus SARS-CoV-2
CordenPharma, a full-service Contract Development & Manufacturing Organization (CDMO) for the supply of APIs, Drug Products & Pharmaceutical Packaging, announces the signing of an amendment to their... 
From PR Newswire
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.